To receive all of SpineGuard’s financial information in real time, send a request by email to [email protected].
PARIS, BOULDER (Colorado, USA), MORGANTOWN (West Virginia, USA), September 12, 2022 at 6:00 p.m. CEST – SpineGuard (FR0011464452 – ALSGD, PEA-PME eligible), an innovative company that designs, develops and markets medical devices intended for secure and simplify the placement of bone implants, and Omnia Medical LLC, specializing in the development of innovative solutions for clinically proven surgical techniques, announce the signing of a co-development and exclusive marketing agreement in the field of adult spine surgery in the United States.
Next SpineGuard financial press release: H1 2022 financial results, September 15, 2022 after market close.